Archive for the ‘gad’ tag

Cymbalta DTC print ad

without comments

Click on the image to see the full-sized ad and get all the info on AdPharm.

29 more Cymbalta ads on AdPharm, click here

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Cymbalta for DPNP

without comments

Click on image to view ad details and full-size version on AdPharm

To see all of this brand’s ads on AdPharm, click here

Cipralex

without comments

Click on thumbnail to view the full-size ad on AdPharm

Click on thumbnail to view the full-size ad on AdPharm

In depression and in GAD

Discover the power of Cipralex

Now covered in Ontario and BC

Brand name: Cipralex
Generic name/category: Escitalopram, Enantiopure drugs, Nitriles, Selective serotonin reuptake inhibitors (SSRI)
Company: Lundbeck
Country/Market: Canada, North America
Indication(s)/use: Depression and Generalized Anxiety Disorder (GAD)
Target: Healthcare Professionals (HCP)
Tagline: Discover the power of Cipralex
Medium: Print ad
Size/duration: single-page
Publication/Aired: CMAJ – September 15, 2009

To see all of this brand’s ads on AdPharm, click here

Cymbalta for Fibromyalgia

without comments

Click on thumbnail to view the full-size ad on AdPharm

Click on thumbnail to view the full-size ad on AdPharm

Are you paying the price of fibromyalgia pain?
Cymbalta can help.

Brand name: Cymbalta
Generic name/category: Duloxetine, Serotonin-norepinephrine reuptake inhibitors (SNRI), Thiophenes
Company: Lilly
Country/Market: USA, North America
Indication(s)/use: Fibromyalgia
Target: Consumers (DTC)
Tagline: Fibromyalgia is painful. Cymbalta can help.
Medium: Print ad
Size/duration: single-page and One third of page
Publication/Aired: More – September 2009

To see all of this brand’s ads on AdPharm, click here

Lexapro

without comments

Login or subscribe to view this ad

For the core symptoms of Major Depressive Disorder (MDD) & Generalized Anxiety Disorder (GAD) in adults
See the effect of Lexapro

Proven efficacy in MDD and GAD

Depressed Mood – Tension – Anxiety

[FLASH]Now FDA approved for MDD in adolescents aged 12 to 17

Escitalopram (trade names Lexapro, Cipralex) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of major depressive disorder and generalized anxiety disorder in adults; other indications include social anxiety disorder, panic disorder and obsessive-compulsive disorder. Escitalopram is the S-stereoisomer (enantiomer) of the earlier Lundbeck drug citalopram (Celexa), hence the name escitalopram. Escitalopram is noted for its high selectivity of serotonin reuptake inhibition and, as a result has fewer side effects not related to its serotonergic activity. According to a meta-analysis of 12 new-generation antidepressants, escitalopram and sertraline (Zoloft) are the best in terms of efficacy and acceptability in the acute-phase treatment of adults with major depression; however, sertraline may be a better choice because of the lower cost.

More on Wikipedia

Brand name: Lexapro
Generic name/category: Escitalopram, Selective serotonin reuptake inhibitors (SSRI)
Company: Forest pharmaceuticals
Country/Market: USA, North America
Indication(s)/use: Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD)
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration: two-page
Publication/Aired: Managed Healthcare Executive – August 2009

To see all of this brand’s ads on AdPharm, click here
4 views
Sep 05, 2009

Visit AdPharm.net for more pharmaceutical ads